Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression

• ARTEAGA C. L.

収録刊行物

• J. Clin. Invest.

  J. Clin. Invest. 92 2569-2576, 1993

詳細情報

• CRID: 1570854175410511360
• NII論文ID: 10018168450
• データソース種別:
  • CiNii Articles